Sanofi expands flu vaccines in China
Sanofi-Aventis is to build a new influenza vaccine manufacturing facility in China.
Sanofi-Aventis is to build a new influenza vaccine manufacturing facility in China.
Singapore's biomedical manufacturing output was down again over October, stunting growth for the region's entire manufacturing sector.
The UK has become an unlikely hub for drug counterfeiters, with the UK Medicines and Healthcare products Regulatory Agency (MHRA) last week launching its new three-year action plan to tackle the recent surge in drug fakes head on.